Abstract
Parkinson's is the 2nd most common neurodegenerative disease in which symptoms range from several motor (rigidity, tremors, and bradykinesia) and nonmotor symptoms (cognitive impairment). These symptoms mainly arise due to alterations in dopaminergic pathways that disturb dopamine release, transmission, and storage. Animal models are employed to study human diseases to understand the disease's genetic and pathophysiological aspects. Several pathological conditions, such as the deposition of Lewy bodies, endoplasmic reticulum stress-induced unfolded proteins, and neuroinflammation, result in the degeneration of dopaminergic neurons. These reasons make the screening and evaluation of antiparkinsonian drugs more tedious and difficult. Animal model of Parkinson's includes neurotoxin model (MPTP, 6-OHDA, Paraquat, rotenone] and newer genetic model [α–synuclein, LRKK2, PINK). In this chapter, we have focused on the mode of action, advantages, and disadvantages of animal models of Parkinson's disease.
Related Books
Thriving Across the Lifespan and Around the Globe: Day in the Life Visual Research Approach
Down Country Lanes, Behind Abandoned Houses
An Integrated Geophysical and Geotechnical Assessment of Hazards Around the Abu Serga Church
Serial Killers Around the World: The Global Dimensions of Serial Murder
Jack the Writer: A Verbal & Visual Analysis of the Ripper Correspondence
Drugs Sex, And Crime - Empirical Contributions
Virtual and Classroom Learning in Higher Education: A Guide to Effective Online Teaching
Assessment, Accreditation and Ranking Methods for Higher Education Institutes in India: Current Findings and Future Challenges
Physics Education for Students: An Interdisciplinary Approach
Inside the New University: Prerequisites for a Contemporary Knowledge Production